Cadila Healthcare Ltd. | CADILAHC | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2018
2019
2020
2021
Revenue
Revenue
119,544131,656142,531151,022
Cost of revenue
Cost of revenue
-41,220-47,164-49,200-52,101
Gross Profit
Gross Profit
78,324
84,492
93,331
98,921
Sales, general & ad...
Sales, general and administrative
-49,354-54,761-65,497-65,511
Depreciation
Depreciation and amortization
-5,388-5,986-6,965-7,248
Provision
Provision
0000
Other op inc/exp...
Other operating income/expenses
-495000
Operating income
Operating income EBIT
23,087
23,745
20,869
26,162
 
     
Interest expense
Interest expense
-911-1,935-3,418-1,635
Other income/exp...
Other income(expense)
1,1322,011-2,497-2,051
Profit before tax
Profit before tax
23,308
23,821
14,954
22,476
Income tax & other ta...
Income tax and other taxes
5,6445,3033,1981,472
Net income from c...
Net income from continuing operations
17,66418,51811,75621,004
Extraordinary & disc...
Extraordinary items & Discontinued Ops
-188000
Share of associates
Share of associates
6284690474
Minority Interest
Minority Interest
-346-4990-514
Net Income
Net income
17,758
18,488
11,756
20,964
 
     
NI - Preferred Di...
Net Income after Preferred Dividend and Others
17,75818,48811,75620,964
Basic shares
Basic shares
1,0241,0241,0241,024
Diluted Shares
Diluted Shares
1,0241,0241,0241,024
EPS Basic
EPS Basic in Rupees
17.3518.0611.4820.48
EPS Diluted
EPS Diluted in Rupees
17.35
18.06
11.48
20.48